SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease.
Nat Commun. 2020 May 1;11(1):2127. doi: 10.1038/s41467-020-15983-6.
Nat Commun. 2020.
PMID: 32358544
Free PMC article.